ArticleWorld journal of pediatric surgery2026
Oral and maxillofacial malignancies in children and adolescents: a 17-year single-center retrospective study.
Article in World journal of pediatric surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The primary purpose of this study was to delineate the clinical and pathological characteristics of oral and maxillofacial malignancies in children and adolescents. Methods: This retrospective study included patients who were hospitalized and treated between January 2009 and December 2025. Sex, age at presentation, tumor site, histopathological diagnosis, and treatment data were collected. Descriptive statistics and cluster analyses of clinical and pathological characteristics were conducted using R software. Results: Totally, 52 patients were included in this study; 31 were male, and 21 were female. The median age at presentation was 12.9 years (range 1.8 to 17.7 years). The most common site was the salivary glands ( Conclusion: For oral and maxillofacial malignancies in children and adolescents, individualized treatment based on pathological type, delivered via a multidisciplinary team (MDT) framework, is essential to achieve tumor eradication while preserving normal growth and developmental capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.